Can a longer IV catheter spare patients with difficult veins from repeated needle sticks?
NCT ID NCT07779317
First seen Aug 21, 2026 · Last updated Aug 26, 2026 · Updated 2 times
Summary
This trial asks whether a longer, longer-lasting midline catheter can be placed as successfully and safely as a standard long peripheral IV when both are inserted by specially trained emergency department nurses using ultrasound. Adults with difficult vein access who need an IV will be randomly assigned to receive one of the two devices. Researchers will compare how often insertion succeeds, complication rates, how long the device stays in place, and patient satisfaction. The goal is to see if giving bedside nurses the option to place midline catheters could reduce repeat needle sticks and improve care for patients with hard-to-find veins.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ultrasound-guided single-lumen midline catheter compared with ultrasound-guided long peripheral intravenous catheter
- What this could lead to
- If midline catheters prove as safe and effective as standard long IVs when placed by ER nurses, patients with difficult veins could need fewer repeat needle sticks and enjoy longer-lasting access during hospital stays.
- What could go wrong
- This is a single-center trial, and results may not apply to all hospitals. Midline catheters carry risks like infection or clotting, and success depends on nurse training and patient factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 292 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults 18 years of age or older * Presenting to the Albany Medical Center Emergency Department * Require intravenous access * Have difficult intravenous access (DIVA) defined by at least one of the following: * Two failed attempts at landmark-based or ultrasound-guided peripheral vascular access performed by qualified emergency department staff * A history of or active comorbid condition associated with difficult intravenous access, including: * Implanted vascular access port (current or previous) * End-stage renal disease with dialysis fistula * Sickle cell disease * Current or previous intravenous drug use * Self-reported difficult intravenous access plus one of the following: * A history of requiring two or more IV attempts during a previous healthcare encounter (self-reported or documented in the medical record) * A previous requirement for a rescue vascular access device after failed IV access, including: * Ultrasound-guided peripheral IV * Midline catheter * Peripherally inserted central catheter (PICC) * Central venous catheter (CVC) * Intraosseous catheter Exclusion Criteria: * Younger than 18 years of age * Prisoners * Non-English-proficient patients * Patients in whom the device cannot be adequately stabilized because of tissue injury or treatment involving the available extremities (including burns, complex humeral fractures, or dialysis fistulas) * Patients who lack the capacity to provide informed consent and do not have an authorized legal representative available * Patients without an identifiable target vein on ultrasonography * Patients known to be pregnant * Previous enrollment in the study * Previous withdrawal from the study * Presentation during a period when no study proceduralists are available * Patients for whom the informed consent and enrollment process could delay time-sensitive medical care
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Catheterization are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Albany Medical Center Hospital
RECRUITINGAlbany, New York, 12208, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound vs. touch: which gets the IV right the first time?
- Team approach may cut complications for patients sent home on oxygen
- AI could sharpen emergency diagnoses for chest pain and breathing trouble
- Home hospital care for infections: when does it fail?
- Virtual nature walks may ease pain and fear during needle procedures
- Simple hand exercise may stop dangerous catheter clots